Page 28 - Read Online

Page 14 of 14 Ricci et al. Vessel Plus 2021;5:31 https://dx.doi.org/10.20517/2574-1209.2021.28

affected by cerebral cavernous malformations: new information on CCM2 penetrance. Front Neurol 2018;9:953. DOI PubMed PMC
62. Gunel M, Awad IA, Finberg K, et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N
Engl J Med 1996;334:946-51. DOI PubMed
63. Sahoo T, Johnson EW, Thomas JW, et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral
cavernous malformations (CCM1). Hum Mol Genet 1999;8:2325-33. DOI PubMed
64. Stahl S, Gaetzner S, Voss K, et al. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-
frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Hum Mutat 2008;29:709-17. DOI PubMed
65. Liquori CL, Penco S, Gault J, et al. Different spectra of genomic deletions within the CCM genes between Italian and American CCM
patient cohorts. Neurogenetics 2008;9:25-31. DOI PubMed
66. Cau M, Loi M, Melis M, et al. C329X in KRIT1 is a founder mutation among CCM patients in Sardinia. Eur J Med Genet
2009;52:344-8. DOI PubMed
67. Gallione CJ, Solatycki A, Awad IA, Weber JL, Marchuk DA. A founder mutation in the Ashkenazi Jewish population affecting
messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations. Genet Med 2011;13:662-6. DOI PubMed
PMC
68. Ortiz L, Costa AF, Bellido ML, et al. Study of cerebral cavernous malformation in Spain and Portugal: high prevalence of a 14 bp
deletion in exon 5 of MGC4607 (CCM2 gene). J Neurol 2007;254:322-6. DOI PubMed
69. Mondéjar R, Solano F, Rubio R, et al. Mutation prevalence of cerebral cavernous malformation genes in Spanish patients. PLoS One
2014;9:e86286. DOI PubMed PMC
70. Perne A, Zhang X, Lehmann L, Groth M, Stuber F, Book M. Comparison of multiplex ligation-dependent probe amplification and
real-time PCR accuracy for gene copy number quantification using the beta-defensin locus. Biotechniques 2009;47:1023-8. DOI
PubMed
71. Yao R, Yu T, Qing Y, Wang J, Shen Y. Evaluation of copy number variant detection from panel-based next-generation sequencing
data. Mol Genet Genomic Med 2019;7:e00513. DOI PubMed PMC
72. Verlaan DJ, Siegel AM, Rouleau GA. Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation. Am J Hum
Genet 2002;70:1564-7. DOI PubMed PMC
73. Battistini S, Ricci C. Concern regarding classification of c.703G>A/p.Gly235Arg as a novel missense variant in KRIT1 gene. Hum
Mutat 2020;41:1069-71. DOI PubMed
74. Brunak S, Engelbrecht J, Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol
1991;220:49-65. DOI PubMed
75. Riant F, Odent S, Cecillon M, et al. Deep intronic KRIT1 mutation in a family with clinically silent multiple cerebral cavernous
malformations. Clin Genet 2014;86:585-8. DOI PubMed
76. Spiegler S, Rath M, Hoffjan S, et al. First large genomic inversion in familial cerebral cavernous malformation identified by whole
genome sequencing. Neurogenetics 2018;19:55-9. DOI PubMed
77. Labauge P, Denier C, Bergametti F, Tournier-lasserve E. Genetics of cavernous angiomas. Lancet Neurology 2007;6:237-44. DOI
PubMed
78. Spiegler S, Najm J, Liu J, et al. High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria:
one-third of probands are minors. Mol Genet Genomic Med 2014;2:176-85. DOI PubMed PMC
79. Rath M, Jenssen SE, Schwefel K, et al. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and
CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations. Eur J Med Genet
2017;60:479-84. DOI PubMed
80. Lucas M, Costa AF, Montori M, Solano F, Zayas MD, Izquierdo G. Germline mutations in theCCM1 gene, encoding Krit1, cause
cerebral cavernous malformations. Ann Neurol 2001;49:529-32. PubMed